{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:07:35Z","timestamp":1794535655988,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":11,"publisher":"Springer New York","isbn-type":[{"value":"9781493967018","type":"print"},{"value":"9781493967032","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-6703-2_20","type":"book-chapter","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T23:22:31Z","timestamp":1480548151000},"page":"247-256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Chronic Myeloid Leukemia"],"prefix":"10.1007","author":[{"given":"John","family":"Swansbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"20_CR1","unstructured":"Mitelman F, Johansson B, Mertens F (eds) Mitelman database of chromosome aberrations in cancer. \n                  http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman"},{"key":"20_CR2","unstructured":"Atlas of genetics and cytogenetics in oncology and haematology. \n                  http:\/\/www.atlasgeneticsoncology.org\/"},{"key":"20_CR3","volume-title":"WHO classification of tumours of hematopoietic and lymphoid tissues","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL et al (eds) (2008) WHO classification of tumours of hematopoietic and lymphoid tissues. IARC, Lyon"},{"key":"20_CR4","volume-title":"Cancer cytogenetics","year":"2015","unstructured":"Heim S, Mitelman F (eds) (2015) Cancer cytogenetics, 4th edn. Wiley, Hoboken, NJ","edition":"4"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0165-4608(94)00150-A","volume":"80","author":"E Nacheva","year":"1995","unstructured":"Nacheva E, Holloway T, Carter N et al (1995) Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes. Cancer Genet Cytogenet 80:87\u201394","journal-title":"Cancer Genet Cytogenet"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0165-4608(81)90078-9","volume":"4","author":"Third International Workshop on Chromosomes in Leukemia","year":"1981","unstructured":"Third International Workshop on Chromosomes in Leukemia (1981) Report on essential thrombocythemia. Cancer Genet Cytogenet 4:138\u2013142","journal-title":"Cancer Genet Cytogenet"},{"key":"20_CR7","doi-asserted-by":"crossref","unstructured":"Caramazza D, Begna KH, Gangat N et al (2011) Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients. Leukemia 25(1): 82\u201388","DOI":"10.1038\/leu.2010.234"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/ajh.24196","volume":"90","author":"J Gotlib","year":"2015","unstructured":"Gotlib J (2015) World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management. Am J Haematol 90:1078\u20131089","journal-title":"Am J Haematol"},{"issue":"6","key":"20_CR9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G et al (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Blood 122(6):872\u2013884","journal-title":"Blood"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1182\/blood-2016-01-690230","volume":"127","author":"W Wang","year":"2016","unstructured":"Wang W, Cortes JE, Tang G et al (2016) Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood 127:2742\u20132750","journal-title":"Blood"},{"key":"20_CR11","unstructured":"U.S. National Comprehensive Cancer Network guidelines. \n                  https:\/\/www.nccn.org\/"}],"container-title":["Methods in Molecular Biology","Cancer Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-6703-2_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T15:38:04Z","timestamp":1558107484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-6703-2_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"ISBN":["9781493967018","9781493967032"],"references-count":11,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-6703-2_20","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-6703-2","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]},"assertion":[{"value":"2 December 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}